Yini i-Alirocumab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Alirocumab iyimithi kadokotela esiza ukwehlisa amazinga akho e-cholesterol uma ukudla nokuzivivinya kunganele. Leli ithuluzi elinamandla elisebenza ngendlela ehlukile emithini yendabuko ye-cholesterol efana nama-statins, linikeza ithemba kubantu abadinga usizo olwengeziwe lokuphatha impilo yabo yenhliziyo.

Le mithi ingeyeqembu elisha lemithi ebizwa ngokuthi ama-PCSK9 inhibitors, futhi iza ngomjovo ozinikeza wona ngaphansi kwesikhumba. Ngenkathi umqondo wokuzijova ungase uzizwe umkhulu ekuqaleni, abantu abaningi bakuthola kuba yingxenye elula yomsebenzi wabo ngesiqondiso esifanele elivela eqenjini labo labanakekeli bezempilo.

Yini i-Alirocumab?

I-Alirocumab iyi-antibody eyenziwe ngumuntu eqondiswe kuphrothini ethile emzimbeni wakho ebizwa nge-PCSK9. Cabanga ngayo njengomsizi okhethekile osebenza nesibindi sakho ukuze ususe i-cholesterol eningi egazini lakho.

Ngokungafani nama-statins asebenza ngaphakathi kwamaseli esibindi sakho, i-alirocumab isebenza ngaphandle kwamaseli ngokuvimba iphrothini ye-PCSK9. Le phrothini ngokuvamile ivimbela isibindi sakho ukuthi singasusi i-cholesterol ngempumelelo. Uma i-alirocumab iyivimba, isibindi sakho singenza umsebenzi ongcono kakhulu wokususa i-cholesterol embi ye-LDL egazini lakho.

Umuthi uza njengesixazululo esicacile, esingenambala esipenini esigcwaliswe ngaphambilini noma isirinji. Yenzelwe ukujovwa ngaphansi kwesikhumba, okusho ukuthi uyijova esicutshini esinamanzi ngaphansi kwesikhumba sakho, ngendlela efana nendlela abantu abanesifo sikashukela abajova ngayo i-insulin.

Isetshenziselwani i-Alirocumab?

I-Alirocumab isetshenziswa ikakhulukazi ukwehlisa i-cholesterol ye-LDL (i-cholesterol "embi") kubantu abadala abadinga usizo olwengeziwe ngaphandle kokudla, ukuzivivinya, neminye imithi ye-cholesterol. Udokotela wakho angase akubhalele uma une-familial hypercholesterolemia, isimo sezakhi zofuzo esibangela amazinga aphezulu kakhulu e-cholesterol.

Iphinde ibhalelwe abantu abanezifo zenhliziyo nemithambo yegazi futhi abadinga ukunciphisa ingozi yabo yokuhlaselwa yinhliziyo, ukushaywa unhlangothi, noma ezinye izinkinga zenhliziyo ezingathi sína. Lokhu kuhlanganisa iziguli ebezivele zihlaselwe yinhliziyo, ukushaywa unhlangothi, noma izinhlobo ezithile zobuhlungu besifuba obubizwa ngokuthi i-angina engazinzile.

Umuthi ngokuvamile ugcinelwe abantu abangazifinyelelanga izinhloso zabo ze-cholesterol ngemithi ye-statin esetshenziswe ngokugcwele. Abanye abantu abakwazi ukuthatha ama-statin ngenxa yemiphumela emibi efana nobuhlungu bemisipha, futhi i-alirocumab inikeza enye indlela yokulawula i-cholesterol engcono.

Isebenza Kanjani I-Alirocumab?

I-Alirocumab ithathwa njengomuthi oqinile wokwehlisa i-cholesterol osebenza ngendlela eyinkimbinkimbi. Yi-monoclonal antibody eqondiswe ngqo futhi ibopheke kuphrothini ye-PCSK9 egazini lakho.

Nansi indlela esiza ngayo umzimba wakho: Isibindi sakho sinama-receptor akhethekile abamba i-cholesterol egazini lakho bese beyiqeda. Iphrothini ye-PCSK9 isebenza njengomuntu owenza izinkinga, ibhubhisa la ma-receptor awusizo. Uma i-alirocumab ivimba i-PCSK9, ama-receptor amaningi asinda futhi angaqhubeka nokususa i-cholesterol egazini lakho.

Le nqubo inganciphisa i-LDL cholesterol yakho ngamaphesenti angama-45-60% noma ngaphezulu kwabanye abantu. Imiphumela inamandla kakhulu futhi ingabonakala kungakapheli amasonto ambalwa ukuqala ukwelashwa. Ngokungafani neminye imithi esebenza kancane kancane, i-alirocumab inikeza ukuncishiswa kwe-cholesterol okusheshayo futhi okukhulu.

Kufanele Ngiyithathe Kanjani I-Alirocumab?

I-Alirocumab inikezwa njengomjovo ngaphansi kwesikhumba sakho njalo emavikini amabili. Umthamo ojwayelekile ungu-75 mg, nakuba udokotela wakho angase awunyuse ube ngu-150 mg uma kudingeka. Uzoyijova ethangeni lakho, engalweni engenhla, noma esiswini, ujikelezisa izindawo zokujova ukuvimbela ukucasuka kwesikhumba.

Ungayithatha le mithi ngaphandle noma ngaphandle kokudla njengoba ifakwa ngomjovo kunokuba igwinywe. Kodwa-ke, kubalulekile ukuthi uvumele imithi ifinyelele izinga lokushisa legumbi ngaphambi kokuyifaka ngomjovo. Yikhiphe esiqandisini cishe imizuzu engu-15-40 ngaphambi kwesikhathi sakho somjovo.

Umhlinzeki wakho wezempilo uzokufundisa indlela efanele yokufaka umjovo ngesikhathi sokuvakasha kwakho kokuqala. Ipeni elizaliswe ngaphambili lenza inqubo iqonde ngqo, kodwa ukuqeqeshwa okufanele kuqinisekisa ukuthi uzizwa ukhululekile futhi unethemba ngomjovo ngamunye. Abantu abaningi bakuthola kuwusizo ukusetha usuku nesikhathi esivamile sokufaka imijovo yabo ukuze bagcine ukuqina.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Alirocumab?

I-Alirocumab ngokuvamile iyindlela yokwelapha yesikhathi eside ozoqhubeka nayo uma nje isiza amazinga akho e-cholesterol futhi udokotela wakho ekuncoma. Abantu abaningi bayithatha iminyaka kungezinyanga, njengoba i-cholesterol ephezulu ngokuvamile iyisimo esingamahlalakhona esidinga ukuphathwa okuqhubekayo.

Udokotela wakho uzoqapha amazinga akho e-cholesterol njalo, ngokuvamile ewahlola ngemva kwamasonto angu-4-8 okwelashwa bese kuba njalo njalo ezinyangeni ezimbalwa. Lokhu kuhlolwa kusiza ukunquma ukuthi imithi iyasebenza yini ngempumelelo nokuthi ngabe kudingeka yini ukulungiswa komthamo.

Ubude bokwelashwa buxhomeke esimweni sakho ngasinye, okuhlanganisa amazinga akho e-cholesterol, ingozi yesifo senhliziyo, nokuthi usabela kanjani kahle emithini. Abanye abantu bangase bakwazi ukunciphisa umthamo wabo ngokuhamba kwesikhathi, kanti abanye bangase badinge ukuqhubeka nohlelo olufanayo unomphela.

Yiziphi Imiphumela Eceleni ye-Alirocumab?

Abantu abaningi bayayibekezelela kahle i-alirocumab, kodwa njengayo yonke imithi, ingabangela imiphumela emibi. Imiphumela emibi evame kakhulu ngokuvamile ithambile futhi ilawuleka ngokunakekela okufanele nokuqapha.

Nawa amanye imiphumela emibi evamile ongase uyithole:

• Ukusabela endaweni yokujova njengobubomvu, ukuvuvukala, noma ububele
• Izimpawu ezinjengomkhuhlane kubandakanya ikhala eligobayo noma umphimbo obuhlungu
• Izimpawu ezinjengomkhuhlane njengokukhathala noma ubuhlungu bemisipha
• Ukuqina noma ukuqubuka kwesikhumba
• Izifo zomgudu womchamo
• Ukuqunjelwa noma isisu esibuhlungu

Le miphumela emibi ivame ukuthuthuka njengoba umzimba wakho ujwayela umuthi. Ukushintshanisa izindawo zokujova kanye nezinqubo ezifanele zokujova kungasiza ekunciphiseni ukusabela kwesikhumba.

Ngenkathi kungavamile, abanye abantu bangase babe nemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha:

• Ukusabela okukhulu komzimba okunzima ukuphefumula, ukuvuvukala kobuso noma umphimbo
• Ubuhlungu bemisipha obuqhubekayo noma ubuthakathaka
• Izimpawu zezinkinga zesibindi njengokuphuzi kwesikhumba noma amehlo
• Ukusabela okukhulu endaweni yokujova okungathuthuki

Xhumana nomhlinzeki wakho wezempilo uma unezimpawu ezikhathazayo noma uma imiphumela emibi iphazamisa impilo yakho yansuku zonke.

Ubani Ongafanele Athathe I-Alirocumab?

I-Alirocumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungile yini kuwe. Abantu abaziwa ukuthi banezinto ezingezwani ne-alirocumab noma ezinye zezithako zayo kufanele bagweme lo muthi.

Udokotela wakho uzoba nokuqapha okukhethekile uma unomlando wokungezwani komzimba okukhulu neminye imithi noma uma unezimo ezithile zezokwelapha. Abesifazane abakhulelwe akufanele bathathe i-alirocumab ngaphandle kokuthi izinzuzo ezingaba khona zidlula izingozi ngokusobala, njengoba imiphumela yayo ezinganeni ezisakhula ingaziwa ngokugcwele.

Uma uncelisa, xoxa ngalokhu nodokotela wakho, njengoba kungacaci ukuthi umuthi udlulela obisini. Abantu abanezifo ezinzima zezinso noma zesibindi bangase badinge ukuqapha okukhethekile noma ukulungiswa komthamo.

Izingane nentsha ngokuvamile akufanele zithathe i-alirocumab ngaphandle uma zine-hypercholesterolemia yomndeni engathi sína futhi ezinye izindlela zokwelapha zingasebenzi. Ukuphepha nokusebenza ezigulini ezinganeni kusafundwa.

Amagama Omkhiqizo we-Alirocumab

I-Alirocumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Praluent e-United States nakwamanye amazwe amaningi. Leli yigama elivame kakhulu ozolibona emiyalelweni kanye nakumakhemisi.

Umuthi ukhiqizwa yi-Regeneron Pharmaceuticals kanye ne-Sanofi, futhi utholakala kuphela njengomuthi wegama lomkhiqizo. Njengamanje, akukho okuhlukile kwe-generic kwe-alirocumab okutholakalayo, okusho ukuthi kungaba kubiza kakhulu ngaphandle komshwalense.

Ezinye izinhlelo zomshwalense zingase zidinge imvume ngaphambi kokumboza i-Praluent, futhi udokotela wakho angase adinge ukukhombisa ukuthi eminye imithi ye-cholesterol ayisebenzanga kuwe.

Ezinye Izindlela ze-Alirocumab

Uma i-alirocumab ingakulungele, ezinye izinketho zingasiza ekuphatheni amazinga akho e-cholesterol. I-Evolocumab (Repatha) ingenye i-PCSK9 inhibitor esebenza ngendlela efana ne-alirocumab kodwa ingase ithandwe kangcono ngabanye abantu.

Imithi ye-statin yendabuko efana ne-atorvastatin (Lipitor) noma i-rosuvastatin (Crestor) ihlala iyindlela yokwelapha yomugqa wokuqala kubantu abaningi abane-cholesterol ephezulu. Le mithi yomlomo ngokuvamile iyasebenza futhi ayibizi kakhulu kune-PCSK9 inhibitors.

Ezinye izindlela zihlanganisa i-ezetimibe (Zetia), evimba ukumuncwa kwe-cholesterol emathunjini akho, kanye ne-bile acid sequestrants efana ne-cholestyramine. Kubantu abane-triglycerides ephezulu kakhulu, imithi efana ne-icosapent ethyl (Vascepa) ingase ibe usizo.

Izinketho ezintsha zihlanganisa i-bempedoic acid (Nexletol) kanye ne-inclisiran (Leqvio), esebenza ngezindlela ezihlukene zokwehlisa i-cholesterol. Udokotela wakho uzokusiza ukuthi uthole inhlanganisela engcono kakhulu yokwelashwa ngokusekelwe ezidingweni zakho ezithile kanye nezimo.

Ingabe i-Alirocumab Ingcono Kune-Evolocumab?

Bobabili i-alirocumab kanye ne-evolocumab bangabavimbeli be-PCSK9 abasebenza ngendlela efanayo futhi banokuphumelela okufanayo ekwehliseni amazinga e-cholesterol. Ucwaningo lubonisa ukuthi womabili lawo machiza anganciphisa i-LDL cholesterol ngama-50-60% noma ngaphezulu uma engezwa emithini ye-statin.

Ukukhetha phakathi kwawo kuvame ukuncika ezintweni zomuntu ngamunye njengamaphrofayili emiphumela emibi, amashejuli okulinganisa, kanye nokumbozwa komshuwalense. I-Alirocumab ivamise ukunikezwa njalo emavikini amabili, kuyilapho i-evolocumab inganikezwa njalo emavikini amabili noma njalo ngenyanga, kuye ngomthamo.

Abanye abantu bangakwazi ukubekezelela enye kangcono kunenye, futhi udokotela wakho angashintsha imithi uma uba nemiphumela emibi. Zombili zinamaphrofayili okuphepha afanayo, kodwa izimpendulo zomuntu ngamunye zingahluka.

Izindleko nokumbozwa komshuwalense kuvame ukudlala indima ebalulekile esinqumweni, njengoba womabili lawo machiza ebiza. Udokotela wakho nomuthi wakho bangakusiza ukuthi uzulazule kulokhu okucatshangelwayo okusebenzayo ngenkathi uqinisekisa ukuthi uthola ukuphathwa kwe-cholesterol okuphumelelayo.

Imibuzo Evame Ukubuzwa Mayelana ne-Alirocumab

Ingabe i-Alirocumab iphephile kubantu abanesifo sikashukela?

Yebo, i-alirocumab ngokuvamile iphephile kubantu abanesifo sikashukela futhi ingaba usizo ikakhulukazi ngoba isifo sikashukela sikhulisa ingozi yesifo senhliziyo. Ucwaningo lubonisa ukuthi i-alirocumab ayithinti ngokuphawulekayo amazinga kashukela egazi, okuyenza ibe yindlela enhle ezigulini ezinomdlavuza sikashukela ezidinga ukuphathwa kwe-cholesterol okukhulu.

Abantu abanesifo sikashukela bavame ukuba nezinto eziningi eziyingozi zenhliziyo, futhi imiphumela enamandla yokwehlisa i-cholesterol ye-alirocumab ingasiza ukunciphisa ingozi yabo yesifo senhliziyo esiphelele. Udokotela wakho uzoqapha kokubili i-cholesterol yakho namazinga kashukela egazi njalo ukuze aqinisekise ukuphathwa okungcono kakhulu kwazo zombili izimo.

Ngingenzani uma ngiphuthelwa ukusebenzisa i-Alirocumab eningi kakhulu?

Uma ngabe uzifake ngengozi i-alirocumab eningi kunaleyo oyalelwe yona, xhumana nomhlinzeki wakho wezempilo noma isikhungo sokulawula ubuthi ngokushesha. Nakuba ukweqisa ngale mithi kungavamile, kubalulekile ukuthola isiqondiso esivela ochwepheshe mayelana nezinyathelo ezilandelayo.

Ungazami ukulinganisa ukweqisa ngokweqa umthamo wakho olandelayo. Kunalokho, landela imiyalelo kadokotela wakho mayelana nokuthi ungaqala nini kabusha uhlelo lwakho lokulinganisa olujwayelekile. Gcina ukupakishwa komuthi kulungile uma ushayela ucingo ukuze uthole usizo, njengoba lolu lwazi luzosiza abahlinzeki bezempilo.

Kufanele ngenzeni uma ngiphuthelwa umthamo we-Alirocumab?

Uma uphuthelwa umthamo wakho we-alirocumab ohleliwe, yifake ngokushesha lapho ukhumbula khona, uma nje kungaphakathi kwezinsuku eziyisikhombisa zomthamo wakho ophuthelwe. Bese uqhubeka nohlelo lwakho olujwayelekile lamasonto amabili kusukela ngalelo phuzu.

Uma sekudlule izinsuku ezingaphezu kweziyisikhombisa kusukela kumthamo wakho ophuthelwe, weqe ngokuphelele bese ulinda umjovo wakho olandelayo ohleliwe. Ungaphindi kabili imithamo ukuze ulungise okungaphuthelwanga, njengoba lokhu kungandisa ingozi yakho yemiphumela emibi.

Ngingayeka nini ukuthatha i-Alirocumab?

Kufanele uyeke kuphela ukuthatha i-alirocumab ngaphansi kokuqondisa kukadokotela wakho. I-cholesterol ephezulu ngokuvamile yisimo esingamahlalakhona esidinga ukwelashwa okuqhubekayo, futhi ukuyeka umuthi cishe kuzobangela ukuthi amazinga akho e-cholesterol anyuke futhi kungakapheli amasonto ambalwa.

Udokotela wakho angase acabange ukuyeka noma ukunciphisa umthamo uma amazinga akho e-cholesterol elawulwe kahle isikhathi eside futhi ezinye izici eziyingozi zithuthukile. Nokho, lesi sinqumo kufanele senziwe ngaso sonke isikhathi kanye nomhlinzeki wakho wezempilo ngokusekelwe esimweni sakho somuntu siqu.

Ngingahamba nge-Alirocumab?

Yebo, ungahamba nge-alirocumab, kodwa kudinga ukuhlela okuthile njengoba umuthi udinga ukufakwa esiqandisini. Uma undiza, yithwale emthwalweni wakho wokuqhubeka onelayebula kadokotela kanye nencwadi evela kudokotela wakho echaza isidingo somuthi.

Ukuze uhambe amabanga amade, cabangela ukusebenzisa icala lokupholisa elenzelwe imithi ejovwayo. Umuthi ungagcinwa ezingeni lokushisa elivamile kuze kube yizinsuku ezingama-30, kodwa kungcono ukuwugcina efrijini uma kungenzeka ukuze ugcine ukusebenza kwawo.